Literature DB >> 10852444

Gender-related differences in counterregulatory responses to antecedent hypoglycemia in normal humans.

S N Davis1, C Shavers, F Costa.   

Abstract

Compared to men, inherent counterregulatory responses are reduced in healthy and type 1 diabetic women. Despite this, the prevalence of hypoglycemia in patients with type 1 diabetes (type 1 DM) is gender neutral. The aim of this study was to determine the in vivo mechanism(s) responsible for this apparent clinical paradox. The central importance of antecedent hypoglycemia in causing subsequent counterregulatory failure is now established. We, therefore, hypothesized that a gender-related difference to the blunting effects of prior hypoglycemia may exist, and this could explain why type 1 DM women do not have an increased prevalence of hypoglycemia despite reduced counterregulatory responses. Fifteen healthy male and female individuals (eight men and seven women) underwent four separate 2-day experimental protocols in a randomized fashion. Day 1 involved identical morning and afternoon 2-h hyperinsulinemic (9 pmol/kg x min) glucose clamp studies with 5.1 +/- 0.1, 3.9 +/- 0.1, 3.3 +/- 0.1, or 2.9 +/- 0.1 mmol/L. Day 2 consisted of a single 2-h hypoglycemic clamp of 2.9 +/- 0.1 mmol/L. Insulin levels were similar on both days of each protocol in men and women. After day 1 euglycemia (5.1 +/- 0.1 mmol/L), day 2 counterregulatory responses were significantly increased (P < 0.01) in men relative to women. In women, counterregulatory responses were resistant to the effects of day 1 hypoglycemia. Antecedent hypoglycemia of 3.9, 3.3, and 2.9 +/- 0.1 mmol/L produced 3 +/- 2%, 5 +/- 2%, and 25 +/- 4% aggregate reductions in day 2 neuroendocrine, muscle sympathetic nerve activity, and metabolic counterregulatory responses. In marked contrast, identical day 1 hypoglycemia of 3.9, 3.3, and 2.9 +/- 0.1 mmol/L in men produced significantly greater reductions in day 2 counterregulatory responses of 30 +/- 6%, 39 +/- 6%, and 52 +/- 6%, respectively. The net effect of the differential gender effects of antecedent hypoglycemia was to overcome the usually increased (50%) sympathetic nervous system (SNS) counterregulatory responses to hypoglycemia found in men. We conclude that 1) antecedent hypoglycemia produces less blunting of counterregulatory responses to subsequent hypoglycemia in women relative to men; 2) two episodes of antecedent hypoglycemia can overcome the greater SNS response to hypoglycemia usually found in men; and 3) the reduced susceptibility of women to the blunting effects of antecedent hypoglycemia may be the mechanism explaining why, despite inherently reduced SNS counterregulatory responses, female type 1 DM patients have a similar prevalence of hypoglycemia compared to men.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852444     DOI: 10.1210/jcem.85.6.6641

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  Sex-specific acclimation of A2 noradrenergic neuron dopamine-β-hydroxylase and estrogen receptor variant protein and 5'-AMP-Activated protein kinase reactivity to recurring hypoglycemia in rat.

Authors:  K P Briski; Md Haider Ali; Prabhat R Napit
Journal:  J Chem Neuroanat       Date:  2020-06-26       Impact factor: 3.052

Review 2.  Sex-steroid-dependent plasticity of brain-stem autonomic circuits.

Authors:  Erica L Littlejohn; Stephanie Fedorchak; Carie R Boychuk
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2020-06-03       Impact factor: 3.619

3.  Combinatory high-resolution microdissection/ultra performance liquid chromatographic-mass spectrometry approach for small tissue volume analysis of rat brain glycogen.

Authors:  Khaggeswar Bheemanapally; Mostafa M H Ibrahim; Karen P Briski
Journal:  J Pharm Biomed Anal       Date:  2019-09-30       Impact factor: 3.935

4.  Recurrent Hypoglycemia Exacerbates Cerebral Ischemic Damage in Diabetic Rats via Enhanced Post-Ischemic Mitochondrial Dysfunction.

Authors:  Vibha Shukla; Perry Fuchs; Allen Liu; Charles H Cohan; Chuanhui Dong; Clinton B Wright; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Transl Stroke Res       Date:  2018-03-22       Impact factor: 6.829

5.  Effects of equivalent sympathetic activation during hypoglycemia on endothelial function and pro-atherothrombotic balance in healthy individuals and obese standard treated type 2 diabetes.

Authors:  Nino G Joy; Maia Mikeladze; Lisa M Younk; Donna B Tate; Stephen N Davis
Journal:  Metabolism       Date:  2016-09-12       Impact factor: 8.694

6.  Free fatty acids are associated with pulse pressure in women, but not men, with type 1 diabetes mellitus.

Authors:  Baqiyyah Conway; Rhobert W Evans; Linda Fried; Sheryl Kelsey; Daniel Edmundowicz; Trevor J Orchard
Journal:  Metabolism       Date:  2009-07-01       Impact factor: 8.694

7.  Ultra-High-Performance Liquid Chromatography-Electrospray Ionization-Mass Spectrometry for High-Neuroanatomical Resolution Quantification of Brain Estradiol Concentrations.

Authors:  Khaggeswar Bheemanapally; Mostafa M H Ibrahim; Karen P Briski
Journal:  J Pharm Biomed Anal       Date:  2020-09-12       Impact factor: 3.935

Review 8.  Defective counterregulation and hypoglycemia unawareness in diabetes: mechanisms and emerging treatments.

Authors:  Candace M Reno; Marina Litvin; Amy L Clark; Simon J Fisher
Journal:  Endocrinol Metab Clin North Am       Date:  2012-12-12       Impact factor: 4.741

9.  Plasma Epinephrine Contributes to the Development of Experimental Hypoglycemia-Associated Autonomic Failure.

Authors:  Eric Lontchi-Yimagou; Sandra Aleksic; Raphael Hulkower; Rebekah Gospin; Akankasha Goyal; Bryan Kuo; William G Mitchell; Jee Young You; Laxmi Upadhyay; Michelle Carey; Oana A Sandu; Ilan Gabriely; Harry Shamoon; Meredith Hawkins
Journal:  J Clin Endocrinol Metab       Date:  2020-11-01       Impact factor: 5.958

10.  Incidence and predictors of hypoglycaemia in type 2 diabetes - an analysis of the prospective DiaRegis registry.

Authors:  Diethelm Tschöpe; Peter Bramlage; Christiane Binz; Michael Krekler; Evelin Deeg; Anselm K Gitt
Journal:  BMC Endocr Disord       Date:  2012-10-17       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.